Through overexpression of PD-L1 on the cancer cell surface or inducing PD-L1/CTLA-4 expression on immune cells, cancer cells use the PD-1/PD-L1 and CTLA-4 pathway resulting in immune escape and tumor growth. This evidence concerns the gene CTLA4 and neoplasm.